Trevi Therapeutics, Inc.

Ownership Transactions Reported by 23 Insiders

Symbol
TRVI on Nasdaq
Industry
Pharmaceutical Preparations
Location
195 Church Street, 14 Th Floor, New Haven, CT

Insiders trading volume in the past year

Trevi Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
New Enterprise Associates 16, L.P. 10%+ Owner $21.1M Apr 11, 2022
Forest Baskett 10%+ Owner $21.1M Apr 11, 2022
Tpg Gp A, Llc Former 10% Owner $7.73M Jul 1, 2022
Carmen Chang 10%+ Owner $7.61M Apr 11, 2022
Ali Behbahani 10%+ Owner $7.61M Apr 11, 2022
Mohamad Makhzoumi 10%+ Owner $7.61M Apr 11, 2022
Scott D. Sandell 10%+ Owner $7.61M Apr 11, 2022
Anthony A. Florence Jr. 10%+ Owner $7.61M Apr 11, 2022
Peter W. Sonsini 10%+ Owner $7.61M Apr 11, 2022
Paul Edward Walker 10%+ Owner $7.61M Apr 11, 2022
Thomas Sciascia Chief Scientific Officer $1.46M -$17.4K -1.17% May 31, 2025
Jennifer L. Good President & CEO, Director $1.4M -$34.6K -2.41% May 31, 2025
David P. Meeker Director $1.03M Jun 11, 2025
Farrell Simon Chief Commercial Officer $550K -$549K -50% May 31, 2025
Lisa Delfini Chief Financial Officer $33K May 31, 2025
Christopher Galletta Controller and Principal Accounting Officer $10.2K May 31, 2025
Anne Vanlent Director Jun 11, 2025
David J. Clark Chief Medical Officer Feb 15, 2024
Dominick Colangelo Director Jun 11, 2025
Edward T. Mathers Director Jun 11, 2025
James V. Cassella Chief Development Officer Feb 18, 2025
William P. Forbes Chief Development Officer Jun 29, 2022
Michael Thomas Heffernan Director Jun 11, 2025

Recent Insider Transactions by Companies or Individuals for Trevi Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.